Compare ABOS & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABOS | SRBK |
|---|---|---|
| Founded | 1996 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.4M | 140.5M |
| IPO Year | 2021 | 2023 |
| Metric | ABOS | SRBK |
|---|---|---|
| Price | $2.31 | $18.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 353.3K | 50.1K |
| Earning Date | 05-12-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ 138.36 |
| EPS | N/A | ★ 0.31 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $60.74 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.10 | $13.40 |
| 52 Week High | $3.60 | $19.61 |
| Indicator | ABOS | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 43.62 | 56.43 |
| Support Level | $2.14 | $18.36 |
| Resistance Level | $2.42 | $19.07 |
| Average True Range (ATR) | 0.14 | 0.31 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 26.64 | 63.51 |
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers. The product pipelines include: ALTITUDE-AD; and INTERCEPT-AD.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.